InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,293.51
(
-0.21%
)
US TECH 100
18,316.20
(
-0.01%
)
Dow Jones
38,772.25
(
-0.76%
)
Brent Oil
84.25
(
1.69%
)
Bitcoin
68,204.99
(
-1.71%
)
Post# of 617862
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

02opida

Send PM Follow Ignore
Followers 1169
Posts 169120
Boards Moderated 5
Alias Born 12/20/2003

02opida

Member Level

Re: 02opida post# 616917

Sunday, 04/28/2024 7:48:50 AM

Sunday, April 28, 2024 7:48:50 AM

Post# of 617862
RKV - Rakovina Therapeutics ends 2023 with cash of $436,313
[2024-04-26 20:47]
Rakovina Therapeutics Inc. had cash and cash equivalents of $436,313 at Dec. 31, 2023. The company spent $419,482 on research and development and had a net loss of $722,733 in the year ended Dec. 31, 2023

History.htm

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up